That’s exactly what’s happening with L patients, as well.

>>What typically happens is there will be some initial improvement but then the cancer returns with vengeance as it mutates into a form without those select antigens.

Danish, you spend 24/7 putting these elaborate pieces together on behalf of the company, so why can’t you just reach out to them for a simple one paragraph statement on the validity of who is saying what, and then post it here?

It’s really up to you Happy. Why not simply send management (whoever that is at this point since LP doesn’t speak) his post to ask if it’s legitimate? While you’re at it why not ask if Weingrow is allowed to speak for the company and exactly what he gets paid to do? Instead, just like with Nem, you’ll twist yourself into a pretzel to avoid the likely reality.

These poor souls don’t even know.

>>Investor Relations, Communications consultant.

It’s possible AI is running the company?

https://archive.is/K29Hj

That all sounds likely but as I’ve pointed out before, PPHM was similar and able to pull it off AFTER entrenched management got kicked out. Granted the business was in America so easier to follow or shareholders.

Captain Tuttle!

The endless monthly dilution figures are staggering. I don’t think NWBO shareholders really understand how unusual it is because they’re so numb to it at this point. The only time I’ve ever seen that many shares constantly go out the door is when a OTC sham stock trades in the fractions. Can anyone show us a daily dilution comparison in any stock that has a ~500M market cap? I seriously doubt it.

Definitely worth rewarding her 900M more. 🙄🤷‍♀️

Ordinarily I’d totally agree with you but it’s taken far longer than any other broke biotech I’ve ever seen.

>>It will eventually collapse, in the end

Then even more impressive. So it’s either setting up for maybe the greatest rug pull and joke on retail, or the market really feels its worth that, but then it’s a matter of determining the value between DCVAX and Advent-Sawston?

Yeah, but remember she continues to sell a ton but somehow the share price holds down here at an impressive $300M+ market cap.

Tell him he’s getting off easy compared to the Legacy shareholders but to watch for the next reverse split.🤷‍♀️

Is everyone really going to fall for it again?!!! The ultimate Christmas Gift - Holiday Cheer - Boxing Day - New Year’s Eve approval! Oh come on! Really?🙄

Yeah, but those files are in a limestone mine and will take some time to find.🤷‍♀️

One solution.

https://www.sciencealert.com/simple-supplement-combo-could-help-fight-deadly-brain-cancer

IF it’s real it’s a startup where they’ll be likely starting over on Roswell’s acquired work.

>>The USA site is selected, management personnel are being installed,

We have zero information on what’s going at Unity. Advent almost certainly had some good customers so where are they? Reflected in NWBO’s market cap or not? Why no Advent financials provided?

>>the Unity Campus is utilizing Advent employs to further science and collaboration,

Yes but what exactly you own is unknown. You don’t even have a track record to go by. Just a privately sold CDMO we know sold for $800M plus. So again, why isn’t Advent’s value reflected in the market cap? Or is it but L just has such little value?

>>WE OWN ADVENT, and the expansion at Sawston is large and began on November 20.

Yeah so? It’s been that way for two decades and only sent shareholders down the drain.

>>Plus all the locations have lease and personnel costs as well. I’ve said it SEEMS like the expansion is outstripping the burn rate.

You don’t know any of that to be true. The London lab expanded over the many years just not recently, or so we were told. They’re no expanding in Pittsburgh they’re allegedly (based on some help wanted ad) starting up. And Unity Campus could easily be a just an escape for Advent’s people and business. 🤷‍♀️

That was my hope but if they’re coming in with no Advent revenues I’m not waiting around if LP remains in charge.

>>The only change we will see here is NWBO becoming a CDMO built on the cash from retail investors

Just like their London lab, right? I don’t think anyone really has a clue what went on there.

FDA National Priority (CNPV) Voucher Program Submission
In parallel, SignPath submitted a justification package for review under the FDA’s new National Priority Voucher (CNPV) Program, which rewards development of therapies targeting urgent public health challenges, including conditions with severe unmet need such as glioblastoma.

>>“This is a significant opportunity for the program,” said Michelle Comas, Chief Operating Officer of SignPath Pharma. “The combination of Orphan Drug Designation, Fast Track submission, and the CNPV application positions LipoCurc™ for a potentially accelerated regulatory path as we prepare to meet with the FDA in early 2026.”

https://www.mywabashvalley.com/business/press-releases/ein-presswire/875676991/signpath-pharma-announces-orphan-drug-designation-and-fast-track-submission-for-lipocurc-in-glioblastoma/

That’s big!

https://news.nm.org/faster-approach-determines-brain-cancer-treatment-is-working/

>>Immunotherapy has transformed cancer care by enhancing the body’s immune response to better recognize and attack cancer cells. While immunotherapy has been shown to be effective in many cancers, including lung and breast cancer, it has shown benefit in only a small number of patients with glioblastoma, the most common and aggressive type of primary brain cancer.

https://news.feinberg.northwestern.edu/2025/12/17/noninvasive-treatment-boosts-immune-response-against-glioblastoma/

Through Toucan would be my bet.

There’s Real world evidence and there’s anecdotal real world. I’ve seen maybe half a dozen L cases in more than a decade that seem more than just anecdotal. 🤷‍♀️ That’s not going to cut it, IMO.

900M to keep the lights on! 😂🤕 Yeah, because that’s not the bonus in itself. Amazing that LP would be so bold as to throw the “bonus” package in too. Bet she says Hey, with these dummies why not, let’s try it! For anyone who shows up, I’ll give them lobster rolls just to keep their mouths shut. LOL

Here’s the latest on the subject.

https://futurism.com/future-society/young-kids-using-ai

This is crack to AI. 😂

And shareholders will end up with a CEO CFO running UK manufacturing from the U.S.? That works how exactly?

>>It's make or break for NWBO -- it they fail they'll become a contract manufacturing company.

Makes sense she’d wait until the second to last day of the year to explain it to shareholders. 🙄🤷‍♀️

>>she indicated that we'd be a very different company by the end of this year

Then it’s a lucky thing for shareholders that NWBO is involved with neither.🤔

>>You "hit that nail on the head". BP and Oncology has been a scam for a long time

I bet she’s saying right now “You mean some are actually coming?!!!” Maybe praying for a blizzard.

I’m sure they’re doing everything possible to make LLM’s seem as human as possible, but all they really do is sift through text and splice it all together.

Must secure the vote!

Danish is its dope peddler. 😂

Cleveland Clinic has nothing to say about L.

https://consultqd.clevelandclinic.org/emerging-technologies-in-brain-tumor-management-podcast

It was but I’ll leave that to the chemist.🤷🏻‍♂️ But as an NWBO investor you should probably feel some outrage that no BP came forward to assist DCVAX or children were treated with L. 🤷‍♀️ I’m sure the DietDoc is putting together a piece right now explaining how DCVAX gets around all that. 🙄

>>The part about the “crisscross” was kinda fascinating, too

Whether the share price goes up a little these last two weeks may depend on when it’s believed votes have been secured?

LP may not have counted on mRNA being the UK’s darling and making sure nothing stands in its way. That’s being incredibly generous to DCVAX and LP, of course.

Probably find it was a strong day for dilution with yesterday’s NICE pump?

WHERE’S THE BEEF?